Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature.
-
Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature.
___
- Reis MAG, Harkins D, Krapcho M et al. SEER cancer sta- tistics review, 1975-2003. Bethesda,MD. National Cancer Institute, 2006.
- Gerard Lim CC, Yahaya H. Second Report of the National Cancer Registry Cancer Incidence in Malaysia 2003. National Cancer Registry, Malaysia
- Bouchardy C, Usel M, Verkooijen HM et ak. Changing pat- tern of age specific breast cancer incidence in the Swiss canton of Geneva. Breast Cancer Res Treat 2009;DOI 10.1007/s10549-009-0478-y
- Rainsbury RM. A patient decline mastectomy. Br J Surg 1999;86:1491-2.
- Estevez LG, Cuevas JM, Florian AAJ et al. Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: Efficacy and correlation with biological markers in a phase II multicenter trial. Clin Cancer Res 2003;9:686-692.
- Hind D, Wyld L, Beverley CB, Reed MW. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus); Cocharne data- base Syst Rev 2006;25:CD004272.
- Oura S, Tamaki T, Hirai I et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 2007;14;48-54.
- Verkooijen HM, Fioretta GM, Rapiti E et al. Patients’ re- fusal of surgery strongly impairs breast cancer survival. Ann Surg 2005;242:276-80.
- Hortobagyi GN, Ames FC, Buzdar AU et al. Management of stage III primary breast cancer with primary chemothera- py, surgery and radiation therapy. Cancer 1988;62:2507-16
- Bear HD, Anderson S, Brown A et al. The effect on tu- mor response of adding sequential preoperative docetaxel to preoparative doxorubicin and cyclophos- phamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol2003;21:4165-74.
- Smith IC, Heys SD, Hutcheon AW et al. Neoadjuvant che- motherapy in breast cancer: significantly enhanced re- sponse with docetaxel. J Clin Oncol 2002;20:1456-66.
- Ring A, Webb A, Ashley S et al. Is surgery necessary af- ter complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol 2003;21:4540-5.
- Foudraine NA, Verhoef LC, Burghouts JT. Tamoxifen as sole therapy for primary breast cancer in the elderly pa- tient. Eur J Cancer 1992;28:900-3.
- Hind D, Wild L, Reed MW. Surgery with or without tamoxifen versus tamoxifen alone for older women with operable breast cancer: Cocharne Review. Br J Cancer 2007;96:1025-9.
- Dubois JB, Salomon A, Gary-Bobo J, Gary-Bobo J, Pourquier H, Pujal H. Exclusive radical radiation therapy in breast carcinoma. Radiother Oncol 1991;20:24-9.